<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T05:54:13Z</responseDate>
  <request identifier="oai:figshare.com:article/33814014" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33814014</identifier>
        <datestamp>2026-09-15T17:54:46Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_8</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_39</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_61</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Strains and plasmids used in this study.&lt;/p&gt;</dc:title>
          <dc:creator>Tian Tian He (24377284)</dc:creator>
          <dc:creator>Pu Yu Tang (24377275)</dc:creator>
          <dc:creator>Qian Ru Zhao (7521626)</dc:creator>
          <dc:creator>Jie Zhang (64655)</dc:creator>
          <dc:creator>Pin Nie (183956)</dc:creator>
          <dc:creator>Hong Bing Yu (10320566)</dc:creator>
          <dc:creator>Hai Xia Xie (24377287)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Microbiology</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Ecology</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Developmental Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>separate functional domains</dc:subject>
          <dc:subject>maintains elevated levels</dc:subject>
          <dc:subject>finding may reveal</dc:subject>
          <dc:subject>underlying mechanisms remain</dc:subject>
          <dc:subject>g ., il</dc:subject>
          <dc:subject>promoting tak1 phosphorylation</dc:subject>
          <dc:subject>inhibiting tak1 abrogates</dc:subject>
          <dc:subject>driving tak1 phosphorylation</dc:subject>
          <dc:subject>esej also interacts</dc:subject>
          <dc:subject>dependent inflammatory responses</dc:subject>
          <dc:subject>edwardsiella piscicida &lt;/</dc:subject>
          <dc:subject>κb signaling pathway</dc:subject>
          <dc:subject>esej orchestrates nf</dc:subject>
          <dc:subject>dependent mechanisms</dc:subject>
          <dc:subject>edwardsiella &lt;/</dc:subject>
          <dc:subject>κb pathway</dc:subject>
          <dc:subject>piscicida &lt;/</dc:subject>
          <dc:subject>inflammatory cytokines</dc:subject>
          <dc:subject>dependent k27</dc:subject>
          <dc:subject>vivo &lt;/</dc:subject>
          <dc:subject>κb signaling</dc:subject>
          <dc:subject>κb cascade</dc:subject>
          <dc:subject>κb activation</dc:subject>
          <dc:subject>upon infection</dc:subject>
          <dc:subject>two ubiquitin</dc:subject>
          <dc:subject>transcriptional activity</dc:subject>
          <dc:subject>terminal region</dc:subject>
          <dc:subject>t3ss ).</dc:subject>
          <dc:subject>subsequent degradation</dc:subject>
          <dc:subject>subsequent activation</dc:subject>
          <dc:subject>provide evidence</dc:subject>
          <dc:subject>linked polyubiquitination</dc:subject>
          <dc:subject>interaction increases</dc:subject>
          <dc:subject>increased transcription</dc:subject>
          <dc:subject>important pathogen</dc:subject>
          <dc:subject>essential role</dc:subject>
          <dc:subject>conserved effector</dc:subject>
          <dc:subject>central domain</dc:subject>
          <dc:subject>6 ).</dc:subject>
          <dc:description>&lt;div&gt;&lt;p&gt;&lt;i&gt;Edwardsiella piscicida&lt;/i&gt; PPD130/91 is an important pathogen that infects both fish and humans. Upon infection, &lt;i&gt;E. piscicida&lt;/i&gt; induces strong inflammatory responses through its type III secretion system (T3SS). The underlying mechanisms remain to be defined. Here, we demonstrate that &lt;i&gt;E. piscicida&lt;/i&gt; T3SS effector EseJ activates the NF-κB pathway in macrophages, leading to increased transcription and secretion of multiple pro-inflammatory cytokines (e.g., IL-1β and IL-6). EseJ orchestrates NF-κB signaling by interfering with two ubiquitin-dependent mechanisms that are mediated by separate functional domains of EseJ. EseJ binds to the NF-κB subunit p65 via its N-terminal region of amino acids 1–242, preventing the K48-linked polyubiquitination of p65 and its subsequent degradation by the proteasome. This maintains elevated levels of total and phosphorylated p65 (p-p65), facilitating p65 nuclear translocation and enhancing its transcriptional activity. EseJ also interacts with TAK1 and TRAF6 (both are upstream of the NF-κB signaling pathway) via its central domain (aa 243–532), thereby promoting the formation of a stable TRAF6-TAK1 complex. This interaction increases the TRAF6-dependent K27-linked polyubiquitination of TAK1, driving TAK1 phosphorylation and the subsequent activation of the IKK-IκB-NF-κB cascade. Inhibiting TAK1 abrogates this signaling, confirming the essential role of TAK1 in EseJ-induced NF-κB activation. &lt;i&gt;In vivo&lt;/i&gt; studies using zebrafish larvae also demonstrated that EseJ is required for &lt;i&gt;E. piscicida&lt;/i&gt; to induce the production of pro-inflammatory cytokines. Together, we provide evidence that EseJ targets both TAK1 and p65 to promote NF-κB-dependent inflammatory responses. Given the similarities among EseJ homologues in other bacteria, our finding may reveal a conserved effector-mediated immune signaling across diverse Gram-negative pathogens.&lt;/p&gt;&lt;/div&gt;</dc:description>
          <dc:date>2026-09-15T17:54:32Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.ppat.1014260.t001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Strains_and_plasmids_used_in_this_study_p_/33814014</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
